New form of immunotherapy under investigation for cancer that resists conventional T cell therapies

by

Medical investigators are theorizing that a combination of two treatments that activate myeloid cells may effectively treat a recalcitrant form of pancreatic cancer that thwarts conventional immunotherapy.

Leave A Comment

Your email address will not be published. Required fields are marked *